Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald B Kohn

Showing results (41-50 of 273) with videos related to

Pageof 28
Sort By:
Current Opinion in Molecular Therapeutics|November 7, 2003
Update on gene therapy of inherited immune deficienciesBarbara C Engel, Donald B Kohn, Greg M Podsakoff
Gene Therapy|November 7, 2023
Successes and challenges in clinical gene therapyDonald B Kohn, Yvonne Y Chen, Melissa J Spencer
Cell Stem Cell|November 4, 2017
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons LearnedRichard A Morgan, David Gray, Anastasia Lomova, et al.
Current Protocols in Human Genetics|April 23, 2008
Human hematopoietic cell culture, transduction, and analysesJesper Bonde, Louisa Wirthlin, Donald B Kohn, et al.
Molecular Therapy. Methods & Clinical Development|January 2, 2023
Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testingKenneth Cornetta, Tsai-Yu Lin, Danilo Pellin, et al.
Journal of Virology|June 14, 2003
Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytesCarolyn Lutzko, Dinithi Senadheera, Dianne Skelton, et al.
Journal of Virology|July 29, 2004
Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integrationAaron C Logan, Dennis L Haas, Tal Kafri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 27, 2024
Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapyEugenio Montini, Luigi Naldini, Claire Booth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2025
Response to: Safety and efficacy considerations of HSC-based gene therapy for RAG1-deficient SCIDEugenio Montini, Luigi Naldini, Claire Booth, et al.
Molecular Therapy Oncolytics|December 23, 2021
Improved lentiviral vector titers from a multi-gene knockout packaging lineJiaying Han, Kevin Tam, Curtis Tam, et al.
Pageof 28

Showing results (41-50 of 273) with videos related to

Sort By:
Pageof 28
Current Opinion in Molecular Therapeutics|November 7, 2003
Update on gene therapy of inherited immune deficienciesBarbara C Engel, Donald B Kohn, Greg M Podsakoff
Gene Therapy|November 7, 2023
Successes and challenges in clinical gene therapyDonald B Kohn, Yvonne Y Chen, Melissa J Spencer
Cell Stem Cell|November 4, 2017
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons LearnedRichard A Morgan, David Gray, Anastasia Lomova, et al.
Current Protocols in Human Genetics|April 23, 2008
Human hematopoietic cell culture, transduction, and analysesJesper Bonde, Louisa Wirthlin, Donald B Kohn, et al.
Molecular Therapy. Methods & Clinical Development|January 2, 2023
Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testingKenneth Cornetta, Tsai-Yu Lin, Danilo Pellin, et al.
Journal of Virology|June 14, 2003
Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytesCarolyn Lutzko, Dinithi Senadheera, Dianne Skelton, et al.
Journal of Virology|July 29, 2004
Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integrationAaron C Logan, Dennis L Haas, Tal Kafri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 27, 2024
Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapyEugenio Montini, Luigi Naldini, Claire Booth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2025
Response to: Safety and efficacy considerations of HSC-based gene therapy for RAG1-deficient SCIDEugenio Montini, Luigi Naldini, Claire Booth, et al.
Molecular Therapy Oncolytics|December 23, 2021
Improved lentiviral vector titers from a multi-gene knockout packaging lineJiaying Han, Kevin Tam, Curtis Tam, et al.
Pageof 28